Viking Therapeutics
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
9920 Pacific Heights Blvd Ste 500, San D...Phone Number
(858) 704-4660Website
www.vikingtherapeutics.comRevenue
$124.7 MillionStock Symbol
VKTXIndustry
ZI Rank: 2
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
3
1
1
2
2
2
About Viking Therapeutics
Viking Therapeutics, founded in 2012, is a clinical-stage biopharmaceutical company focused on developing novel, orally available therapies for metabolic and endocrine disorders. The company specializes in research and development of innovative therapeutics targeting metabolism to improve patient outcomes. Viking Therapeutics has multiple clinical programs in its portfolio, including treatments for lipid and metabolic disorders, X-linked adrenoleukodystrophy, and solutions for patients recovering from hip fractures. The company also has earlier-stage programs targeting metabolic diseases and anemia. Viking Therapeutics holds exclusive worldwide rights to a portfolio of therapeutic programs based on small molecules licensed from other pharmaceutical companies. The company is publicly traded and maintains operations across multiple locations in North America.Explore more
Viking Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Viking Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Viking Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Viking Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Check out if Viking Therapeutics is spiking on competitors!
Earning: See what the market has to say on Viking Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Viking Therapeutics launches new products
Check if Viking Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Viking Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Viking Therapeutics
Recommended Actions
Reach out to Masked Content who joined Viking Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Viking Therapeutics
Compare insights from companies similar to Viking Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Viking Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Viking Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Viking Therapeutics.
Viking Therapeutics financials insights
Gather financial insights about Viking Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$24M
Viking Therapeutics Tech Stack
A closer look at the technologies used by Viking Therapeutics
Most Recent Scoops
Open Position
Hiring Plans
Viking Therapeutics has more open roles in Engineering & Technical than it has had at any time in the past 12 months.
Hiring Plans
Project
reported that participants in the phase II VENTURE study receiving weekly subcutaneous VK2735 doses achieved statistically significant mean body weight reductions of up to 14.7% after 13 weekly doses with no signs of plateau, with the compound demonstrating a safe and well-tolerated profile, and final results published in January of this year in the peer-reviewed journal "Obesity."
Medical Research, Pharmaceuticals
Earnings
Viking Therapeutics has reported a net loss of $286.5 million, or $2.47 per share, for the six months ended June 30, 2026, compared to a net loss of $111.2 million, or $0.99 per share, for the same period in 2025, with the increase primarily driven by higher research and development and general and administrative expenses.
Earnings, Research & Development, Finance
Project
Pharmaceuticals, Clinical Operations
Viking Therapeutics News & Media
Novo Nordisk Falls 7% as Post-Wegovy Growth Plan Fails to Ease Competition Fears; Eli Lilly Slips, Viking Therapeutics Edges Higher
Novo Nordisk took the stage at its own capital markets day and said something that sent its stock tumbling 7%, yet its closest rivals barely flinched. What the company revealed about its future tells investors exactly how much trouble the Ozempic empire may be in.Wall Street Sees a Huge Rebound for Viking Therapeutics. Here's Why Analysts Are So Optimistic.
The weight loss market is highly competitive, but Viking only needs to carve out a small niche in it with VK2735 in order to generate significant value for investors.Axsome Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Axsome is already selling drugs with 65% revenue growth, while Viking bets on obesity treatments still in trials, a classic choice between proven sales and blockbuster potential.Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case.
Investors always need to appreciate risk before buying into any clinical-stage biopharmaceutical company.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Viking Therapeutics
Sign Up For FreeTo access detailed company insights
Viking Therapeutics, founded in 2012, is a clinical-stage biopharmaceutical company focused on developing novel, orally available therapies for metabolic and endocrine disorders. The company specializes in research and development of innovative therapeutics targeting metabolism to improve patient outcomes. Viking Therapeutics has multiple clinical... Read More
